SHARONBIO

Sharon Bio-Medicine Limited has informed the Exchange about Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about Closure of trading window

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about update on committee of creditors meeting

Sharon Bio-Medicine Limited has informed the Exchange about commencement of corporate insolvency resolution process

Sharon Bio-Medicine Limited has informed the Exchange about communication to shareholders as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange about Newspaper Advertisements

Sharon Bio-Medicine Limited has informed the Exchange about Revised Auditor's Report for the quarter and year ended March 31, 2022

Sharon Bio-Medicine Limited has informed the Exchange about Board Meeting held on 17-May-2022 to consider financial statements for the period ended March 2022

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Confirmation Certificate under Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Intimation of Closure of Trading Window

Sharon Bio-Medicine Limited has informed the Exchange about Order passed by Hon'ble Supreme Court

Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on February 07, 2022.

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'NCLAT Order dated January 5, 2022'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021.Pursuant to Regulation 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti on the Unaudited Financial Results of the Company for the quarter and half year en

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and Participants) Regulations 2018'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Newspaper Publication of Unaudited Financial Results��

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.

Subject: Disclosure under Regulation 23(9) of SEBI (LODR) Regulation, 2015 Pursuant to the Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, there were no related party transactions for the half year ended March 31, 2021.Kindly take the above information on your records.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 Kindly take the same on your record and acknowledge the receipt. '.

Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed from July 1, 2021 till Forty Eight (48) hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2021.��Currently, the trading is temporarily suspended for capital reduction process and would be resumed upon requisite approval from regulators.��Kindly take the above on record.

Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Audited Financial Results of the Company for the quarter and year ended March 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on Jun 23, 2021.

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Publication for intimation of Audited Financial Results '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Subject: Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 '.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Intimation of Closure of Trading Window '.

Sharon Bio-Medicine Limited has informed the Exchange regarding Limited Review Report for the Quarter ended December 31, 2020

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Newspaper Publication of Unaudited Financial ResultsPursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on February 12, 2021.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Publication for Intimation of Unaudited financial results Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter ended December 31, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Dear Sir/Madam, Subject: Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 With reference to the above referred subject, we are enclosing herewith the Confirmation Certificate dated January 28, 2021 received from M/s. Link Intime India Private Limited, the Register and Share Transfer Agent of our Company for the quarter ended December 31, 2020.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Sub: Newspaper Publication of Unaudited Financial ResultsPursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and half year ended September 30, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding Board meeting held on November 11, 2020.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Pursuant to Clause 47 of the Listing Obligations and Disclosure Requirements Regulations, 2015 (LODR) we enclose advertisements given in Free Press Journal and Navshakti relating to the consideration and approval of Unaudited financial results of the Company for the quarter and half year ended September 30, 2020.Kindly take the same on your records.'.

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Certificate under Regulation 74 (5) of Securities and Exchange Board of India (Depositories and participants) Regulations 2018 '.

Sharon Bio-Medicine Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Sharon Bio-Medicine Limited has informed the Exchange regarding 'Newspaper Publication of Unaudited Financial Results'.

Sharon Bio-Medicine Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.